Follow the people · Insider
Roger Adsett
Roger Adsett files insider transactions with the SEC as a chief operating officer of Insmed (INSM). We hold 8 disclosed purchases and sales filed since 4 October 2016, 1 of them in the last 90 days.
- Files forINSM
- Disclosed buys and sells8 in all, 1 in the last 90 days
- Last disclosure12 August 2026
Positions held
3 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 3 October 2016 — 10 August 2026Chief Operating Officer · Insmed (INSM)98 Form 4 lines · source: SEC Form 4
- Filed 29 January 2026 — 11 June 2026Director · Definium Therapeutics (DFTX)4 Form 4 lines · source: SEC Form 4
- Filed 8 March 2022 — 23 May 2024Director · Landos Biopharma (LABP)6 Form 4 lines · source: SEC Form 4
Everything they disclosed
108 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 82,280 shares of InsmedSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- exercised options over 76,600 shares of InsmedSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- exercised options over 80,970 shares of InsmedSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- ▼ sold on the open market 239,850 shares of InsmedSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- exercised options over 82,280 shares of Insmed (a derivative holding)SEC Form 412 August 2026Stock Option (right to buy) · traded 10 August 2026 · filed 12 August 2026
- exercised options over 76,600 shares of Insmed (a derivative holding)SEC Form 412 August 2026Stock Option (right to buy) · traded 10 August 2026 · filed 12 August 2026
- exercised options over 80,970 shares of Insmed (a derivative holding)SEC Form 412 August 2026Stock Option (right to buy) · traded 10 August 2026 · filed 12 August 2026
- was granted 3,555 shares of Definium TherapeuticsSEC Form 415 June 2026Common Shares · traded 11 June 2026 · filed 15 June 2026
- was granted 14,620 shares of Definium Therapeutics (a derivative holding)SEC Form 415 June 2026Stock Option (Right to Buy) · traded 11 June 2026 · filed 15 June 2026
- ▼ sold on the open market 2,370 shares of InsmedSEC Form 45 June 2026Common Stock · traded 3 June 2026 · filed 5 June 2026
- ▼ sold on the open market 5,837 shares of InsmedSEC Form 415 May 2026Common Stock · traded 13 May 2026 · filed 15 May 2026
- exercised options over 88,060 shares of InsmedSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- ▼ sold on the open market 6,715 shares of InsmedSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- ▼ sold on the open market 19,001 shares of InsmedSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- ▼ sold on the open market 62,344 shares of InsmedSEC Form 43 April 2026Common Stock · traded 1 April 2026 · filed 3 April 2026
- exercised options over 88,060 shares of Insmed (a derivative holding)SEC Form 43 April 2026Stock Option (right to buy) · traded 1 April 2026 · filed 3 April 2026
- ▼ sold on the open market 791 shares of InsmedSEC Form 44 February 2026Common Stock · traded 3 February 2026 · filed 4 February 2026
- ▼ sold on the open market 791 shares of InsmedSEC Form 44 February 2026Common Stock · traded 3 February 2026 · filed 4 February 2026
- was granted 50,000 shares of Definium Therapeutics (a derivative holding)SEC Form 429 January 2026Stock Option (Right to Buy) · traded 29 January 2026 · filed 29 January 2026
- was granted 50,000 shares of Definium Therapeutics (a derivative holding)SEC Form 429 January 2026Stock Option (Right to Buy) · traded 29 January 2026 · filed 29 January 2026
- ▼ sold on the open market 1,429 shares of InsmedSEC Form 48 January 2026Common Stock · traded 6 January 2026 · filed 8 January 2026
- ▼ sold on the open market 802 shares of InsmedSEC Form 48 January 2026Common Stock · traded 7 January 2026 · filed 8 January 2026
- ▼ sold on the open market 2,059 shares of InsmedSEC Form 48 January 2026Common Stock · traded 8 January 2026 · filed 8 January 2026
- ▼ sold on the open market 1,429 shares of InsmedSEC Form 48 January 2026Common Stock · traded 6 January 2026 · filed 8 January 2026
- ▼ sold on the open market 802 shares of InsmedSEC Form 48 January 2026Common Stock · traded 7 January 2026 · filed 8 January 2026
- ▼ sold on the open market 2,059 shares of InsmedSEC Form 48 January 2026Common Stock · traded 8 January 2026 · filed 8 January 2026
- was granted 5,998 shares of InsmedSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- was granted 31,280 shares of Insmed (a derivative holding)SEC Form 46 January 2026Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 31,280 shares of Insmed (a derivative holding)SEC Form 46 January 2026Stock Option (right to buy) · traded 2 January 2026 · filed 6 January 2026
- was granted 5,998 shares of InsmedSEC Form 46 January 2026Common Stock · traded 2 January 2026 · filed 6 January 2026
- ▼ sold on the open market 20,193 shares of InsmedSEC Form 421 August 2025Common Stock · traded 19 August 2025 · filed 21 August 2025
- ▼ sold on the open market 4,807 shares of InsmedSEC Form 421 August 2025Common Stock · traded 19 August 2025 · filed 21 August 2025
- ▼ sold on the open market 6,500 shares of InsmedSEC Form 418 June 2025Common Stock · traded 16 June 2025 · filed 18 June 2025
- ▼ sold on the open market 4,186 shares of InsmedSEC Form 418 June 2025Common Stock · traded 16 June 2025 · filed 18 June 2025
- ▼ sold on the open market 1,860 shares of InsmedSEC Form 44 June 2025Common Stock · traded 3 June 2025 · filed 4 June 2025
- was granted 31,610 shares of Insmed (a derivative holding)SEC Form 419 May 2025Stock Option (right to buy) · traded 15 May 2025 · filed 19 May 2025
- was granted 6,508 shares of InsmedSEC Form 419 May 2025Common Stock · traded 15 May 2025 · filed 19 May 2025
- ▼ sold on the open market 7,482 shares of InsmedSEC Form 415 May 2025Common Stock · traded 13 May 2025 · filed 15 May 2025
- ▼ sold on the open market 1,925 shares of InsmedSEC Form 415 May 2025Common Stock · traded 14 May 2025 · filed 15 May 2025
- ▼ sold on the open market 11,053 shares of InsmedSEC Form 412 February 2025Common Stock · traded 10 February 2025 · filed 12 February 2025
- ▼ sold on the open market 5,781 shares of InsmedSEC Form 412 February 2025Common Stock · traded 10 February 2025 · filed 12 February 2025
- ▼ sold on the open market 26,141 shares of InsmedSEC Form 412 February 2025Common Stock · traded 10 February 2025 · filed 12 February 2025
- was granted 88,680 shares of InsmedSEC Form 47 February 2025Common Stock · traded 5 February 2025 · filed 7 February 2025
- ▼ sold on the open market 45,605 shares of InsmedSEC Form 47 February 2025Common Stock · traded 6 February 2025 · filed 7 February 2025
- ▼ sold on the open market 100 shares of InsmedSEC Form 47 February 2025Common Stock · traded 7 February 2025 · filed 7 February 2025
- ▼ sold on the open market 1,457 shares of InsmedSEC Form 416 January 2025Common Stock · traded 14 January 2025 · filed 16 January 2025
- was granted 31,930 shares of Insmed (a derivative holding)SEC Form 410 January 2025Stock Option (right to buy) · traded 8 January 2025 · filed 10 January 2025
- ▼ sold on the open market 2,444 shares of InsmedSEC Form 410 January 2025Common Stock · traded 7 January 2025 · filed 10 January 2025
- ▼ sold on the open market 1,882 shares of InsmedSEC Form 410 January 2025Common Stock · traded 8 January 2025 · filed 10 January 2025
- was granted 6,657 shares of InsmedSEC Form 410 January 2025Common Stock · traded 8 January 2025 · filed 10 January 2025
- ▼ sold on the open market 1,298 shares of InsmedSEC Form 410 January 2025Common Stock · traded 10 January 2025 · filed 10 January 2025
- ▼ sold on the open market 3,604 shares of InsmedSEC Form 410 January 2025Common Stock · traded 10 January 2025 · filed 10 January 2025
- returned to the issuer 1,800 shares of Landos Biopharma (a derivative holding)SEC Form 423 May 2024Stock Option (right to buy) · traded 23 May 2024 · filed 23 May 2024
- returned to the issuer 1,800 shares of Landos Biopharma (a derivative holding)SEC Form 423 May 2024Stock Option (right to buy) · traded 23 May 2024 · filed 23 May 2024
- returned to the issuer 3,600 shares of Landos Biopharma (a derivative holding)SEC Form 423 May 2024Stock Option (right to buy) · traded 23 May 2024 · filed 23 May 2024
- ▼ sold on the open market 5,945 shares of InsmedSEC Form 417 May 2024Common Stock · traded 17 May 2024 · filed 17 May 2024
- was granted 71,160 shares of Insmed (a derivative holding)SEC Form 415 May 2024Stock Option (right to buy) · traded 13 May 2024 · filed 15 May 2024
- was granted 14,518 shares of InsmedSEC Form 415 May 2024Common Stock · traded 13 May 2024 · filed 15 May 2024
- ▼ sold on the open market 7,857 shares of InsmedSEC Form 415 May 2024Common Stock · traded 14 May 2024 · filed 15 May 2024
- ▼ sold on the open market 5,251 shares of InsmedSEC Form 412 January 2024Common Stock · traded 12 January 2024 · filed 12 January 2024
- ▼ sold on the open market 3,837 shares of InsmedSEC Form 411 January 2024Common Stock · traded 9 January 2024 · filed 11 January 2024
- ▼ sold on the open market 3,536 shares of InsmedSEC Form 411 January 2024Common Stock · traded 10 January 2024 · filed 11 January 2024
- was granted 63,560 shares of Insmed (a derivative holding)SEC Form 45 January 2024Stock Option (right to buy) · traded 4 January 2024 · filed 5 January 2024
- was granted 12,873 shares of InsmedSEC Form 45 January 2024Common Stock · traded 4 January 2024 · filed 5 January 2024
- ▼ sold on the open market 3,042 shares of InsmedSEC Form 45 January 2024Common Stock · traded 5 January 2024 · filed 5 January 2024
- ▼ sold on the open market 8,981 shares of InsmedSEC Form 415 June 2023Common Stock · traded 13 June 2023 · filed 15 June 2023
- was granted 18,000 shares of Landos Biopharma (a derivative holding)SEC Form 424 May 2023Stock Option (right to buy) · traded 23 May 2023 · filed 24 May 2023
- ▼ sold on the open market 2,847 shares of InsmedSEC Form 417 May 2023Common Stock · traded 15 May 2023 · filed 17 May 2023
- ▼ sold on the open market 1,521 shares of InsmedSEC Form 417 May 2023Common Stock · traded 16 May 2023 · filed 17 May 2023
- ▼ sold on the open market 2,448 shares of InsmedSEC Form 417 May 2023Common Stock · traded 17 May 2023 · filed 17 May 2023
- was granted 146,220 shares of Insmed (a derivative holding)SEC Form 415 May 2023Common Stock · traded 11 May 2023 · filed 15 May 2023
- was granted 31,662 shares of InsmedSEC Form 415 May 2023Common Stock · traded 11 May 2023 · filed 15 May 2023
- ▼ sold on the open market 3,194 shares of InsmedSEC Form 412 January 2023Common Stock · traded 10 January 2023 · filed 12 January 2023
- was granted 34,860 shares of Insmed (a derivative holding)SEC Form 46 January 2023Stock Option (right to buy) · traded 5 January 2023 · filed 6 January 2023
- ▼ sold on the open market 3,044 shares of InsmedSEC Form 46 January 2023Common Stock · traded 5 January 2023 · filed 6 January 2023
- was granted 7,598 shares of InsmedSEC Form 46 January 2023Common Stock · traded 5 January 2023 · filed 6 January 2023
- ▼ sold on the open market 11,855 shares of InsmedSEC Form 422 November 2022Common Stock · traded 22 November 2022 · filed 22 November 2022
- was granted 18,000 shares of Landos Biopharma (a derivative holding)SEC Form 49 June 2022Stock Option (right to buy) · traded 7 June 2022 · filed 9 June 2022
- ▼ sold on the open market 1,394 shares of InsmedSEC Form 418 May 2022Common Stock · traded 16 May 2022 · filed 18 May 2022
- ▼ sold on the open market 2,022 shares of InsmedSEC Form 418 May 2022Common Stock · traded 17 May 2022 · filed 18 May 2022
- was granted 129,490 shares of Insmed (a derivative holding)SEC Form 413 May 2022Stock Option (right to buy) · traded 11 May 2022 · filed 13 May 2022
- was granted 27,460 shares of InsmedSEC Form 413 May 2022Common Stock · traded 11 May 2022 · filed 13 May 2022
- was granted 36,000 shares of Landos Biopharma (a derivative holding)SEC Form 410 March 2022Stock Option (right to buy) · traded 8 March 2022 · filed 10 March 2022
- ▼ sold on the open market 1,217 shares of InsmedSEC Form 413 January 2022Common Stock · traded 12 January 2022 · filed 13 January 2022
- was granted 85,690 shares of Insmed (a derivative holding)SEC Form 410 January 2022Stock Option (right to buy) · traded 6 January 2022 · filed 10 January 2022
- was granted 17,735 shares of InsmedSEC Form 410 January 2022Common Stock · traded 6 January 2022 · filed 10 January 2022
- ▼ sold on the open market 3,068 shares of InsmedSEC Form 47 January 2022Common Stock · traded 5 January 2022 · filed 7 January 2022
- ▼ sold on the open market 1,759 shares of InsmedSEC Form 47 January 2022Common Stock · traded 6 January 2022 · filed 7 January 2022
- had shares withheld for tax on 2,477 shares of InsmedSEC Form 418 May 2021Common Stock · traded 15 May 2021 · filed 18 May 2021
- was granted 14,172 shares of InsmedSEC Form 414 May 2021Common Stock · traded 12 May 2021 · filed 14 May 2021
- was granted 68,640 shares of Insmed (a derivative holding)SEC Form 414 May 2021Stock Option (right to buy) · traded 12 May 2021 · filed 14 May 2021
- was granted 11,019 shares of InsmedSEC Form 48 January 2021Common Stock · traded 7 January 2021 · filed 8 January 2021
- was granted 54,720 shares of Insmed (a derivative holding)SEC Form 48 January 2021Stock Option (right to buy) · traded 7 January 2021 · filed 8 January 2021
- had shares withheld for tax on 1,690 shares of InsmedSEC Form 46 January 2021Common Stock · traded 15 May 2020 · filed 6 January 2021
- had shares withheld for tax on 2,275 shares of InsmedSEC Form 46 January 2021Common Stock · traded 3 January 2021 · filed 6 January 2021
- had shares withheld for tax on 1,223 shares of InsmedSEC Form 46 January 2021Common Stock · traded 4 January 2021 · filed 6 January 2021
- was granted 141,300 shares of Insmed (a derivative holding)SEC Form 47 January 2020Stock Option (right to buy) · traded 3 January 2020 · filed 7 January 2020
- was granted 26,315 shares of InsmedSEC Form 47 January 2020Common Stock · traded 3 January 2020 · filed 7 January 2020
- had shares withheld for tax on 1,414 shares of InsmedSEC Form 47 January 2020Common Stock · traded 3 January 2020 · filed 7 January 2020
- was granted 24,863 shares of InsmedSEC Form 420 November 2019Common Stock · traded 18 November 2019 · filed 20 November 2019
- was granted 21,559 shares of InsmedSEC Form 416 May 2019Common Stock · traded 15 May 2019 · filed 16 May 2019
- was granted 231,310 shares of Insmed (a derivative holding)SEC Form 47 January 2019Stock Option · traded 3 January 2019 · filed 7 January 2019
- ▲ bought on the open market 3,000 shares of InsmedSEC Form 42 November 2018Common Stock · traded 1 November 2018 · filed 2 November 2018
- was granted 15,594 shares of InsmedSEC Form 48 January 2018Common Stock · traded 4 January 2018 · filed 8 January 2018
- was granted 80,970 shares of Insmed (a derivative holding)SEC Form 48 January 2018Stock Option · traded 4 January 2018 · filed 8 January 2018
- was granted 76,600 shares of Insmed (a derivative holding)SEC Form 419 May 2017Stock Option · traded 17 May 2017 · filed 19 May 2017
- was granted 82,280 shares of Insmed (a derivative holding)SEC Form 49 January 2017Stock Option · traded 5 January 2017 · filed 9 January 2017
- was granted 88,060 shares of Insmed (a derivative holding)SEC Form 44 October 2016Stock Option · traded 3 October 2016 · filed 4 October 2016
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.